<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> should be treated with bone marrow transplantation if possible </plain></SENT>
<SENT sid="1" pm="."><plain>Various clinical and experimental data support the view that the major pathogenetic defect in SAA is a dysregulated cellular immune response which in turn has a negative effect upon hematopoiesis </plain></SENT>
<SENT sid="2" pm="."><plain>Therefore a large percentage of patients react favorably to treatment with <z:chebi fb="1" ids="35705">immunosuppressive agents</z:chebi> as antithymocyte globulin and high-dose <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Data concerning the efficiency of <z:chebi fb="0" ids="4031">Cyclosporine</z:chebi> A treatment are limited until now </plain></SENT>
<SENT sid="4" pm="."><plain>We present in this report our own experience with <z:chebi fb="0" ids="4031">Cyclosporine</z:chebi> A treatment in three children with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> who lack a bone marrow donor </plain></SENT>
<SENT sid="5" pm="."><plain>Included is also a review of the present therapeutic possibilities </plain></SENT>
</text></document>